VaxArray Potency Kit for “Pandemic” Vaccines Fills Gap in Pandemic Preparedness InDevR’s game-changing VaxArray potency test for influenza H5, H7, and H9 vaccines published in npj Vaccines BOULDER (10/8/18) ...
Read More

First Influenza-Specific Neuraminidase Test Kit InDevR’s game-changing VaxArray® vaccine potency testing platform now includes a reagent kit for rapid assessment of neuraminidase in influenza vaccines BOULDER COLORADO (6/12/18) — InDevR ...
Read More

InDevR publishes high impact article in Vaccine: VaxArray for hemagglutinin and neuraminidase potency testing of influenza vaccines ...
Read More

VaxArray Rapid Response to Seasonal Strain Changes for Influenza Vaccines BOULDER (4/10/18) — InDevR expanded its license agreement with the Technology Transfer Program at the US Food and Drug Administration ...
Read More

21 CFR Part 11 compatible software now available for the VaxArray vaccine potency testing platform!  A new standard in data integrity for vaccine potency testing ...
Read More

InDevR launches a new product that could shave weeks off the timeline to deliver flu vaccines in the event of a pandemic. InDevR has announced that it has expanded its VaxArray® ...
Read More